Independent Analysis and Reportage
Why are some people hit harder by certain diseases than others? Why do some patients respond better to a treatment, while others see no effect? Biomarkers can help answer these questions.
Compounding pharmacies will now be able to sell 6 popular peptides, despite the fact they have not been proved safe and effective.
A new study compared power plants’ carbon emissions and found government-owned plants’ emissions were much higher and less responsive to climate policies.
A big retailer can be both a fierce competitor and a traffic-generating anchor for nearby businesses.
National debt now equals the size of the US economy.
Albert Einstein declared time to be an illusion. Modern cosmologists disagree.
After a decade of rage politics, voters in very different countries seem to be reaching again for competence and something closer to normal.
Children usually arrive in custody having had significant disruption to their education already.
As student protest action spreads across France, controversy over media pluralism exposes deeper inequalities in who gets to speak for the movement and how it is portrayed.
From collagen coffee to skincare derived from salmon sperm, Strange Health investigates whether expensive treatments and supplements can really improve our skin.
The endorsement comes as the treasurer faces heated criticism from within government and without.
A tech CEO’s affair with a suspected Chinese spy is rocking the AI industry.